<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31173159</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1791-244X</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of molecular medicine</Title><ISOAbbreviation>Int J Mol Med</ISOAbbreviation></Journal><ArticleTitle>Resveratrol&#x2011;loaded nanoparticles inhibit enterovirus 71 replication through the oxidative stress&#x2011;mediated ERS/autophagy pathway.</ArticleTitle><Pagination><StartPage>737</StartPage><EndPage>749</EndPage><MedlinePgn>737-749</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/ijmm.2019.4211</ELocationID><Abstract><AbstractText>A number of studies have demonstrated that resveratrol (RES) has a variety of biological functions, including cardiovascular protective effects, treatment of mutations, and anti&#x2011;inflammatory, anti&#x2011;tumor and antiviral effects. In the present study, RES&#x2011;loaded nanoparticles (RES&#x2011;NPs) were used to protect rhabdosarcoma (RD) cells from enterovirus&#xa0;71 (EV71) infection, and the relevant mechanisms were also explored. An amphiphilic copolymer, monomethoxy poly (ethylene glycol)&#x2011;b&#x2011;poly (D,L&#x2011;lactide), was used as vehicle material, and RES&#x2011;NPs with necessitated drug&#x2011;loading content and suitable sizes were prepared under optimized conditions. RES&#x2011;NPs exhibited the ability to inhibit the increase of intracellular oxidative stress. The prospective mechanism for the function of RES&#x2011;NPs suggested was that RES&#x2011;NPs may inhibit the oxidative stress&#x2011;mediated PERK/eIF2&#x3b1;/ATF4 signaling pathway, downregulate the autophagy pathway and resist EV71&#x2011;induced RD cells injury. Furthermore, RES&#x2011;NPs treatment markedly inhibited the secretion of inflammatory factors, including interleukin (IL)&#x2011;6, IL&#x2011;8 and tumor necrosis factor&#x2011;&#x3b1; elicited by EV71 infection. Concomitantly, inhibitors of oxidative stress, endoplasmic reticulum stress (ERS) or autophagy were demonstrated to negate the anti&#x2011;inflammatory and antiviral effects of RES&#x2011;NPs on EV71&#x2011;infected RD cells. These results demonstrated that RES&#x2011;NPs attenuated EV71&#x2011;induced viral replication and inflammatory effects by inhibiting the oxidative stress&#x2011;mediated ERS/autophagy signaling pathway. In view of their safety and efficiency, these RES&#x2011;NPs have potential applications in protecting RD cells from EV71 injury.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Hua</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Wan-Guo</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Int J Mol Med</MedlineTA><NlmUniqueID>9810955</NlmUniqueID><ISSNLinking>1107-3756</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q369O8926L</RegistryNumber><NameOfSubstance UI="D000077185">Resveratrol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059865" MajorTopicYN="N">Endoplasmic Reticulum Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077185" MajorTopicYN="N">Resveratrol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31173159</ArticleId><ArticleId IdType="doi">10.3892/ijmm.2019.4211</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>